STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Verfügbar ab:

Sanofi-Aventis Australia Pty Ltd

INN (Internationale Bezeichnung):

prochlorperazine mesilate

Darreichungsform:

Injection

Zusammensetzung:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Verabreichungsweg:

Intramuscular

Einheiten im Paket:

10 x 1 mL

Verschreibungstyp:

(S1) This Schedule is intentionally blank

Anwendungsgebiete:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Produktbesonderheiten:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2007-07-16